(Q61933950)

English

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma. (English)

0 references

0 references

0 references

May 2000

0 references

number of participants

500

0 references

research intervention

thalidomide

0 references

clinical trial phase

phase III clinical trial

0 references

research site

University of Lille

0 references

research subject recruitment status

completed

0 references

minimum age

65 year

0 references

maximum age

75 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00367185

0 references

(Q61933950)

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)